Bone Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-06-26
Clinical Trial Update: Lenvatinib and Capecitabine in Patients With Advanced Malignancies [Phase 1]
A Phase 1 study of lenvatinib in combination with capecitabine for patients with advanced cancers has been withdrawn.